Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, Xu Y, An K, Zhang Y, Chen R, He L, Wang Q, Wang H, Du Y, Liu R, Huang C, Zhang X, Yang YG, Kan Q, Tian X.
Wang Y, et al. Among authors: he l.
Mol Cancer. 2023 May 9;22(1):81. doi: 10.1186/s12943-023-01780-4.
Mol Cancer. 2023.
PMID: 37161388
Free PMC article.